Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology
Disease Category: Irritable Bowel Syndrome (IBS)
Trial Information
Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS) needed for a clinical research trial
A Phase 2, Multicenter, Randomized, Double-Blind,
Placebo-Controlled, Study To Access The Efficacy And Safety Of
Three Different Doses (275, 550, and 1100 MG) Of Rifaximin
Administered BID For Either Two Or Four Weeks in the Treatment of
Patients With Diarrhea-Associated Irritable Bowel Syndrome
Study visits include a screening visit and 8 office visits over
16 weeks.
Major Inclusion Criteria:
- Female or Male at least 18 years old
- Irritable Bowel Syndrome presenting with diarrhea associated
IBS symptoms
As part of the study, you will receive at no cost:
- Study-related medical care and exams
- Study-related medication
- Compensation up to $300.00 for time and travel
Call today if you would like to learn more about this study and
to find out if you qualify.
Silvia Sanchez, Patient Recruitment Coordinator
Advanced Clinical Research Institute
1211 W. La Palma Ave., Suite 602
Anaheim, CA 92801
Phone: 714-778-1309 x.227
Fax: 714-778-0667
EMail: info@advancedtrials.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
